high-throughput screening KU Leuven-led Project Aims to Develop Mass PCR Testing Platform for Future Pandemics Premium The project, called PCR-4-All, officially commenced Dec. 1 and will run through November 2026. GenScript, Allozymes Partner on Enzyme Discovery and Development Services GenScript will provide mutant synthetic DNA libraries and protein expression while Allozymes will offer high-throughput screening services. Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test The SARS-CoV-2/flu assay is the second test available on the high-throughput BD Cor PX/MX system. BioSpyder Wins High-Throughput Toxicology Screening Contract From EPA The Carlsbad, California-based company said that the contract — its third with the EPA — has a potential value of $25 million over five years. 10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods Premium These hybrid capture-based methods target gene transcripts of interest, which could shrink sequencing costs for some experiments by as much as 90 percent. Apr 15, 2020 Iceland SARS-CoV-2 Screening Effort Finds Lower Infection Incidence in Children, Women Mar 18, 2020 CRISPR Screening Approach for Mapping Genetic Interactions Uncovers Masked Phenotypes Mar 17, 2020 NYGC Researchers Develop CRISPR-Based Screen to Target RNA Viruses Like SARS-CoV-2 Premium Jan 15, 2020 Single Technologies Raises $1.6M to Develop NGS Platform Dec 20, 2019 Large Pan-Cancer CRISPR Screens by Broad, Sanger Institutes Show High Concordance Dec 5, 2019 High-Throughput Single-Cell Transcriptomics Assay Facilitates Compound Screens Premium Aug 15, 2019 NIH, UCSF Researchers Develop CRISPRi Platform for Genetic Screening of Human Neurons Apr 10, 2019 Genome-Scale CRISPR Screening Helps Identify New Cancer Drug Targets Mar 28, 2019 Schizophrenia Genes Prioritized in Zebrafish Mutant Study Oct 18, 2018 Mount Sinai Researchers Develop Protein Barcoding Technology for Single-Cell CRISPR Screening May 11, 2018 PARP Inhibitor Resistance Gene Identified Using CRISPR Screen May 3, 2018 Human Malaria Parasite Mutagenesis Highlights Essential Genes, Potential Drug Targets Sep 27, 2017 CRISPR-Cas9 Screen Points to Potential Vulnerabilities in KRAS-Mutated Colorectal Cancer Jul 26, 2017 PLATE-Seq Method Adds Expression, Regulatory Insights to Cell Screens Premium Mar 21, 2017 Bay Area's Innovative Genomics Institute Launches Entrepreneurially Focused 'Super-Postdoc' Program Premium Mar 20, 2017 CRISPR Method Used to Detect Synthetic Lethalities in Cancer Mar 8, 2017 New CRISPR Dual-Guide RNA Library Design Tool Powers Functional Studies of lncRNAs Premium Dec 16, 2016 CRISPR Screen IDs Hundreds of Functional lncRNAs in Human Cells Premium Oct 31, 2016 CRISPR Deletion-Based Screen Identifies Functional Long Non-Coding RNAs Oct 28, 2016 CRISPR Plus Single-Cell Sequencing Combines Benefits of Pooled, Arrayed Screens Load More Breaking News SARS-CoV-2 Mutational Signature Associated With Mutagenic Antiviral Drug Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.